Combined Adductor&Sciatic Nerve Block vs Femoral&Sciatic Nerve Block in Total Knee Replacement Surgery
Launched by BAKIRKOY DR. SADI KONUK RESEARCH AND TRAINING HOSPITAL · Dec 12, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
As a result of the power analysis investigators conducted for this study, the minimum sample size was calculated as 34 people for each group, 68 people in total, at the 95% confidence interval.
68 patients who meet the inclusion criteria will be included in our study. Patients will be randomized and divided into 2 groups. Accordingly, femoral and sciatic nerve blocks will be applied to 34 patients, and adductor canal and sciatic nerve blocks will be applied to 34 patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages of 40-85
- • ASA I-III
- • Patients who will undergo total knee replacement surgery under general anesthesia
- Exclusion Criteria:
- • Patients with deformity and pathology in the thigh region
- • Clinically known local anesthetic allergy
- • Clinically diagnosis of opioid, alcohol and substance dependence
- • Patients who cannot perceive and evaluate pain such as psychiatric illness, mental retardation, dementia
- • Morbid obesity (body mass index\> 40 kg m2)
About Bakirkoy Dr. Sadi Konuk Research And Training Hospital
Bakirkoy Dr. Sadi Konuk Research and Training Hospital is a leading healthcare institution dedicated to advancing medical research and education. Located in Istanbul, Turkey, the hospital combines clinical excellence with a robust research framework, focusing on innovative treatment methodologies and patient care. As a prominent clinical trial sponsor, it fosters collaboration among multidisciplinary teams to facilitate groundbreaking studies that enhance medical knowledge and improve health outcomes. The institution is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Bakirkoy, Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials